These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36355192)

  • 1. [Evaluation of the COVID-19 vaccination after broad implementation-an interim conclusion for Germany in July 2022].
    Siedler A; Schönfeld V; Peine C; Perumal N; Friedsam A; Stoliaroff-Pépin A; Harder T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Dec; 65(12):1272-1280. PubMed ID: 36355192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role, working methods and recommendations of the Standing Committee on Vaccinations (STIKO) in the context of the COVID-19 pandemic].
    Vygen-Bonnet S; Schlaberg J; Koch J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Dec; 65(12):1251-1261. PubMed ID: 36416888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of weekly COVID-19 vaccination and case data supports negative correlation between incidence and vaccination in German federal states and cities during 4th wave.
    Springer S; Kaatz M; Zieger M
    Vaccine; 2022 May; 40(22):2988-2992. PubMed ID: 35437192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada.
    Leigh Hobbs J; Paul LA; Buchan SA; Harris T; Wilson SE
    Vaccine; 2023 May; 41(21):3328-3336. PubMed ID: 37087395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the screening method for estimating COVID-19 vaccine effectiveness using routine surveillance data: Germany's experience during the COVID-19 pandemic, July 2021 to March 2023.
    Perumal N; Schönfeld V; Wichmann O
    Euro Surveill; 2024 Feb; 29(8):. PubMed ID: 38390650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System.
    Semenzato L; Botton J; Baricault B; Deloumeaux J; Joachim C; Sylvestre E; Dray-Spira R; Weill A; Zureik M
    PLoS One; 2022; 17(9):e0274309. PubMed ID: 36084113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Crisis management at the Robert Koch Institute during the COVID-19 pandemic and the exchange between federal and state governments].
    Halm A; Grote U; An der Heiden M; Hamouda O; Schaade L; Rexroth U;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Apr; 64(4):418-425. PubMed ID: 33666683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany.
    Fiske A; Schönweitz F; Eichinger J; Zimmermann B; Hangel N; Sierawska A; McLennan S; Buyx A
    PLoS One; 2022; 17(4):e0266659. PubMed ID: 35390085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies.
    Fu Y; Zhao J; Wei X; Han P; Yang L; Ren T; Zhan S; Li L
    Front Public Health; 2022; 10():917732. PubMed ID: 35928479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
    Rosero-Bixby L
    JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the COVID-19 immunisation programme through a national immunisation Management system - England's experience.
    Tessier E; Edelstein M; Tsang C; Kirsebom F; Gower C; Campbell CNJ; Ramsay M; White J; Andrews N; Lopez-Bernal J; Stowe J
    Int J Med Inform; 2023 Feb; 170():104974. PubMed ID: 36577202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccination during pregnancy: coverage and safety.
    Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
    Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between vaccine coverage and the COVID-19 pandemic throughout the world: Based on real-world data.
    Huang C; Yang L; Pan J; Xu X; Peng R
    J Med Virol; 2022 May; 94(5):2181-2187. PubMed ID: 35075651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covid-19 vaccination programme effectiveness against SARS-CoV-2 related infections, hospital admissions and deaths in the Apulia region of Italy: a one-year retrospective cohort study.
    Homan T; Mazzilli S; Chieti A; Musa A; Roth A; Fortunato F; Bisceglia L; Prato R; Lopalco PL; Martinelli D
    Sci Rep; 2022 Nov; 12(1):18597. PubMed ID: 36329239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of a SARS-CoV-2 test strategy in a southwestern university hospital at the beginning of the COVID-19 pandemic].
    Trimborn A; Gerigk M; Heininger A; Santhanam N; Walter T; Lange B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Mar; 64(3):353-359. PubMed ID: 33580269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the safety and efficacy of current COVID-19 vaccines.
    Huang Z; Su Y; Zhang T; Xia N
    Front Med; 2022 Feb; 16(1):39-55. PubMed ID: 35122210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco.
    Belayachi J; Obtel M; Mhayi A; Razine R; Abouqal R
    PLoS One; 2022; 17(12):e0278546. PubMed ID: 36477077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants.
    Damasceno DHP; Amaral AA; Silva CA; Simões E Silva AC
    Curr Med Chem; 2022; 29(15):2673-2690. PubMed ID: 34473613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.